HERON THERAPEUTICS, INC. /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 1.02 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2020-03-02
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 1.02M shares, a 53.06% increase from fiscal 2018.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 667.34K shares, a 32.86% decline from fiscal 2017.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 993.92K shares, a 40.46% increase from fiscal 2016.
- HERON THERAPEUTICS, INC. /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 707.62K shares, a 40.58% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|
| 2019-12-31 | 1.02M shares 10-K · filed 2020-03-02 |
| 2018-12-31 | 667.34K shares 10-K · filed 2019-02-22 |
| 2017-12-31 | 993.92K shares 10-K · filed 2018-02-27 |
| 2016-12-31 | 707.62K shares 10-K · filed 2017-02-23 |
| 2015-12-31 | 503.34K shares 10-K · filed 2016-02-19 |
| 2014-12-31 | 806.51K shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |